• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Alzheimer's Clinical Trials Consortium Down Syndrome

Alzheimer's Clinical Trials Consortium Down Syndrome

  • About Us
  • Projects
  • Sites
  • News
  • Alzheimer’s in Down Syndrome
  • Contact Us

People

Keith Johnson, MD

Keith Johnson, MD

Brigham and Women's Hospital, Massachusetts General Hospital, Harvard Medical School

Keith Johnson, M.D., leads the ACTC PET Imaging Unit, and is a Professor of Radiology at Harvard Medical School and Director of Molecular Neuroimaging in the Department of Radiology at Massachusetts General Hospital. Dr. Johnson has extensive experience in imaging research in neurodegenerative diseases, is a PI of the Harvard Aging Brain Study, and oversees the brain PET imaging program at MGH, which includes active research programs in imaging of amyloid-beta and PHF tau. Dr. Johnson leads the PET component of the A4 Study, as well as several other AD clinical trials. In addition, Dr. Johnson is a practicing Neurologist, Associate Physician in Neurology at Massachusetts General Hospital, and Associate Neurologist in the Division of Cognitive and Behavioral Neurology at Brigham and Women’s Hospital. He oversees the Clinical Brain PET Service at the MGH.

Footer

ACTC DS and NIA/NIH logos

ACTC is funded by a Cooperative Agreement from the National Institute on Aging, National Institutes of Health.  Cooperative Agreement number U24AG057437.

  • About Us
  • Projects
  • Sites
  • News
  • Alzheimer’s in Down Syndrome
  • Contact Us
  • Privacy Policy
  • Terms of Use
  • California Privacy Rights
Learn more about ACTC

Copyright © 2023 · Urbi on Genesis Framework · WordPress · Log in

Copyright © USC ATRI 2023. All Rights Reserved.